Since the 2018 ISPAD guidelines on this topic, follow‐up of large cohorts from around the
globe have continued informing the current incidence and prevalence of co‐morbidities and …

Background The incidence of type 2 diabetes in young people is increasing, but treatments
remain limited. We aimed to assess the efficacy and safety of an empagliflozin dosing …

This mini-review aims to briefly summarize the pathophysiology of childhood obesity, type 2
diabetes mellitus (T2DM), and cardiovascular disease (CVD) risk in children and …

Background Incidence of type 2 diabetes (T2D) in children and adolescents is increasing,
but treatment options are limited. Methods This was a 26-week, phase 3 trial with a 26-week …

Objective To assess the efficacy and safety of sitagliptin in youth with type 2 diabetes (T2D)
inadequately controlled with metformin±insulin. Study Design Data were pooled from two 54 …

Abstract Type 2 diabetes (T2D) in youth is a global health concern characterized by an
increasing incidence and prevalence, especially among disadvantaged socioeconomic …

Methods The literature search was conducted in the PubMed database to identify all
relevant original English articles published from the beginning of 2018 until January 2023 …

Objective: The occurrence of partial remission (honeymoon phase) in type 1 diabetes (T1D)
has been associated with a reduced risk of chronic microvascular complications of diabetes …

Childhood-onset obesity has emerged as a major public healthcare challenge across the
globe, fueled by an obesogenic environment and influenced by both genetic and epigenetic …

Background Growing evidence indicates that incretin‐based therapies (IBTs), glucagon‐like
peptide‐1 receptor agonists (GLP‐1 RAs), and dipeptidyl peptidase‐4 inhibitors (DPP4is) …